Two new additions to the growing scientific (as opposed to the ideological) literature on reduced-risk nicotine products (e-cigarettes in shorthand) show more clearly their high likelihood of benefiting smokers trying to quit smoking.

Of all the garbage science topics that we routinely cover, among the worst is the concept that miniscule amounts of so-called endocrine disruptors chemicals that supposedly have an adverse impact on human sexual development do anything whatsoever. The plastic component BPA and plastic softeners, phthalates, are the two poster children of the movement, but there are many more.

Dr. J Cuzick from the Queen Mary University of London and international colleagues from several institutions performed a review of studies linking the use of aspirin to decreased risk of several types of cancer and of heart attacks and stroke.

Last week, Oregon joined the ranks of states trying to pass GMO labeling laws, with the proponents of the bill arguing that consumers have a right to know

Hypertension is well-known to be a major risk factor for all types of cardiovascular disease: stroke and heart attack. Now a study seems to show that mid-life HT may also predict cognitive decline later on.

As we have done repeatedly, fellow debunker Michael Shaw has some things to say about Dr. Oz on his web page Shaw s Eco-Logic.
Here are a couple of examples from his piece The Merry Old Land of Oz, which appeared on the HealthNewsDigest site:

Concussions are a major and growing concern among athletes, and have garnered much media attention recently. Two examples include the long-term effects of concussions and new helmets intended to quantify cumulative impacts to the head. However, concussions among children and adolescents have not been as

A doctor s op-ed in today s NYTimes expresses eloquently the frustration felt by conscientious care-givers over the bureaucratic hassles engendered by preferred drug formularies, supposedly aimed at saving money. Do they, really?

Catch the latest news on concerns regarding Gilead's $84,000 hepatitis C treatment drug Sovaldi, the declining sales of traditional cigarettes, and why prior authorization could be hurting the health care system

The ban on super-sized sodas was finally defeated in New York City, but the attack on sugary beverages is far from over. Last week, Congresswoman Rosa DeLauro (D-CT) introduced a bill in the House the Sugar-Sweetened Beverage Tax Act of 2014 that would put a tax on sugar-sweetened drinks of a penny per teaspoon